Takanori Matsui

Empagliflozin, an Inhibitor of Sodium-Glucose Cotransporter 2 Exerts Anti-Inflammatory and Antifibrotic Effects on Experimental Diabetic Nephropathy Partly by Suppressing AGEs-Receptor Axis

Ayako Ojima, Takanori Matsui, Yoshinori Nishino et al. · Hormone and Metabolic Research · 2015 · 221 citations · Full text

Medicine, Nephrology, Pharmacology +17

Pigment Epithelium-derived Factor Inhibits Advanced Glycation End Product-induced Retinal Vascular Hyperpermeability by Blocking Reactive Oxygen Species-mediated Vascular Endothelial Growth Factor Expression

Sho‐ichi Yamagishi, Kazuo Nakamura, Takanori Matsui et al. · Journal of Biological Chemistry · 2006 · 218 citations · Full text

Medicine, Ophthalmology, Pharmacology +17

Elevated Serum Levels of Pigment Epithelium-Derived Factor in the Metabolic Syndrome

Sho‐ichi Yamagishi, Hisashi Adachi, Akio Abe et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 181 citations · Full text

Medicine, Cardiology, Epidemiology +13

Glucagon-like peptide-1 (GLP-1) inhibits advanced glycation end product (AGE)-induced up-regulation of VCAM-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression

Yuji Ishibashi, Takanori Matsui, Masayoshi Takeuchi et al. · Biochemical and Biophysical Research Communications · 2009 · 172 citations

Life Sciences, Endocrinology, Physiology +14

Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes

Sho‐ichi Yamagishi, Nobutaka Nakamura, Mika Suematsu et al. · Molecular Medicine · 2015 · 172 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +15